METACARE CO., Ltd. (KRX:118000)
South Korea · Delayed Price · Currency is KRW 318.00
0.00 (0.00%)
At close: Sep 15, 2025
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 54.62 billion as of September 15, 2025. Its market cap has decreased by -6.00% in one year.
Market Cap
54.62B
Enterprise Value
96.51B
Revenue
22.21B
Ranking
n/a
PE Ratio
121.99
Stock Price
318.00
Market Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has increased from 39.82B to 54.62B, an increase of 37.19%. That is a compound annual growth rate of 2.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 54.62B | 17.56% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | 143.38B | 61.54% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.88T |
| Celltrion | 37.82T |
| ALTEOGEN | 26.27T |
| Yuhan | 8,955.07B |
| SK Biopharmaceuticals | 8,692.77B |
| Peptron | 7,152.29B |
| PharmaResearch | 6,690.93B |
| ABL Bio | 5,746.76B |